PEG–lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication

References

• Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235–49
   PubMed Web of Science ®Google Scholar
• Johnson JI, Decker S, Zaharevitz D, et al. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 2001;84:1424–31
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007;24:1–16
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001;73:137–72
   PubMed Web of Science ®Google Scholar
• Lasic DD. Mixed micelles in drug delivery. Nature 1992;355:279–80
   PubMed Web of Science ®Google Scholar
• La SB, Okano T, Kataoka K. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 1996;85:85–90
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Omelyanenko VG, Papisov MI, et al. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1994;1195:11–20
   PubMed Web of Science ®Google Scholar
• Sawant RR, Sawant RM, Torchilin VP. Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity. Eur J Pharm Biopharm 2008;70:51–7
   PubMed Web of Science ®Google Scholar
• Veronese FM, Pasut G. PEGylation, successful approach to drug delivery. Drug Discov Today 2005;10:1451–8
   PubMed Web of Science ®Google Scholar
• Schwarz KB, Mohan P, Narkewicz MR, et al. Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 2006;43:499–505
   PubMed Web of Science ®Google Scholar
• Webster R, Didier E, Harris P, et al. PEGylated proteins: evaluation of their safety in the absence of definitive metabolism studies. Drug Metab Dispos 2007;35:9–16
   PubMed Web of Science ®Google Scholar
• Croy SR, Kwon GS. Polymeric micelles for drug delivery. Curr Pharm Des 2006;12:4669–84
   PubMed Web of Science ®Google Scholar
• Naahidi S, Jafari M, Edalat F, et al. Biocompatibility of engineered nanoparticles for drug delivery. J Control Release 2013;166:182–94
   PubMed Web of Science ®Google Scholar
• Roerdink F, Regts J, Van Leeuwen B, Scherphof G. Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats. Biochim Biophys Acta 1984;770:195–202
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice. Pharm Res 2002;19:1424–9
   PubMed Web of Science ®Google Scholar
• Wu H, Zhu L, Torchilin VP. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials 2013;34:1213–22
   PubMed Web of Science ®Google Scholar
• Ashok B, Arleth L, Hjelm RP, et al. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci 2004;93:2476–87
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271–84
   PubMed Web of Science ®Google Scholar
• Taurin S, Nehoff H, Greish K. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link? J Control Release 2012;164:265–75
   PubMed Web of Science ®Google Scholar
• Kim S, Shi Y, Kim JY, et al. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction. Expert Opin Drug Deliv 2010;7:49–62
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev 2011;63:136–51
   PubMed Web of Science ®Google Scholar
• Weissig V, Whiteman KR, Torchilin VP. Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm Res 1998;15:1552–6
   PubMed Web of Science ®Google Scholar
• Remsberg CM, Zhao Y, Takemoto JK, et al. Pharmacokinetic evaluation of a DSPE-PEG2000 micellar formulation of ridaforolimus in rat. Pharmaceutics 2012;5:81–93
   PubMedGoogle Scholar
• Ragi C, Sedaghat-Herati MR, Ouameur AA, Tajmir-Riahi HA. The effects of poly(ethylene glycol) on the solution structure of human serum albumin. Biopolymers 2005;78:231–6
   PubMed Web of Science ®Google Scholar
• Li S, Garreau H, Pauvert B, et al. Enzymatic degradation of block copolymers prepared from epsilon-caprolactone and poly(ethylene glycol). Biomacromolecules 2002;3:525–30
   PubMed Web of Science ®Google Scholar
• Gaucher G, Dufresne MH, Sant VP, et al. Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 2005;109:169–88
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Torchilin VP. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 2004;56:1273–89
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Elbayoumi TA, Chakilam AR, Torchilin VP. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J Control Release 2004;100:135–44
   PubMed Web of Science ®Google Scholar
• Gao Z, Lukyanov AN, Chakilam AR, Torchilin VP. PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing. J Drug Target 2003;11:87–92
   PubMed Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002;82:189–212
   PubMed Web of Science ®Google Scholar
• Holland JW, Hui C, Cullis PR, Madden TD. Poly(ethylene glycol)–lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry 1996;35:2618–24
   PubMed Web of Science ®Google Scholar
• Arleth L, Ashok B, Onyuksel H, et al. Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media. Langmuir 2005;21:3279–90
   PubMed Web of Science ®Google Scholar
• Tao L, Hu W, Liu Y, et al. Shape-specific polymeric nanomedicine: emerging opportunities and challenges. Exp Biol Med (Maywood) 2011;236:20–9
   PubMed Web of Science ®Google Scholar
• Sandstrom MC, Johansson E, Edwards K. Structure of mixed micelles formed in PEG-lipid/lipid dispersions. Langmuir 2007;23:4192–8
   PubMed Web of Science ®Google Scholar
• Johnsson M, Edwards K. Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids. Biophys J 2003;85:3839–47
   PubMed Web of Science ®Google Scholar
• Liu J, Lee H, Allen C. Formulation of drugs in block copolymer micelles: drug loading and release. Curr Pharm Des 2006;12:4685–701
   PubMed Web of Science ®Google Scholar
• Sahib MN, Darwis Y, Peh KK, et al. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations. Int J Nanomedicine 2011;6:2351–66
   PubMed Web of Science ®Google Scholar
• Gill KK, Kaddoumi A, Nazzal S. Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines. Eur J Pharm Sci 2012;46:64–71
   PubMed Web of Science ®Google Scholar
• Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113–31
   PubMed Web of Science ®Google Scholar
• Mu L, Elbayoumi TA, Torchilin VP. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 2005;306:142–9
   PubMed Web of Science ®Google Scholar
• Amiji M. Nanotechnology for cancer therapy. Boca Raton, FL: CRC Press; 2007
   Google Scholar
• Kastantin M, Ananthanarayanan B, Karmali P, et al. Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles. Langmuir 2009;25:7279–86
   PubMed Web of Science ®Google Scholar
• Gill KK, Nazzal S, Kaddoumi A. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation. Eur J Pharm Biopharm 2011;79:276–84
   PubMed Web of Science ®Google Scholar
• Sandvig K, Pust S, Skotland T, Van Deurs B. Clathrin-independent endocytosis: mechanisms and function. Curr Opin Cell Biol 2011;23:413–20
   PubMed Web of Science ®Google Scholar
• Sawant RM, Hurley JP, Salmaso S, et al. “SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 2006;17:943–9
   PubMed Web of Science ®Google Scholar
• Dabholkar RD, Sawant RM, Mongayt DA, et al. Polyethylene glycol-phosphatidylethanolamine conjugate (PEG-PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 2006;315:148–57
   PubMed Web of Science ®Google Scholar
• Wang T, Petrenko VA, Torchilin VP. Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity. Mol Pharm 2010;7:1007–14
   PubMed Web of Science ®Google Scholar
• Hayama A, Yamamoto T, Yokoyama M, et al. Polymeric micelles modified by folate-PEG-lipid for targeted drug delivery to cancer cells in vitro. J Nanosci Nanotechnol 2008;8:3085–90
   PubMed Web of Science ®Google Scholar
• Musacchio T, Laquintana V, Latrofa A, et al. PEG-PE micelles loaded with paclitaxel and surface-modified by a PBR-ligand: synergistic anticancer effect. Mol Pharm 2009;6:468–79
   PubMed Web of Science ®Google Scholar
• Roby A, Erdogan S, Torchilin VP. Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur J Pharm Biopharm 2006;62:235–40
   PubMed Web of Science ®Google Scholar
• Han X, Liu J, Liu M, et al. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro. Int J Pharm 2009;372:125–31
   PubMed Web of Science ®Google Scholar
• Skidan I, Miao B, Thekkedath RV, et al. In vitro cytotoxicity of novel pro-apoptotic agent DM-PIT-1 in PEG-PE-based micelles alone and in combination with TRAIL. Drug Deliv 2009;16:45–51
   PubMed Web of Science ®Google Scholar
• Sawant RR, Torchilin VP. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting. Mol Membr Biol 2010;27:232–46
   PubMed Web of Science ®Google Scholar
• Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 2003;100:6039–44
   PubMed Web of Science ®Google Scholar
• Sawant RR, Torchilin VP. Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. Int J Pharm 2009;374:114–18
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Gao Z, Torchilin VP. Micelles from polyethylene glycol/phosphatidylethanolamine conjugates for tumor drug delivery. J Control Release 2003;91:97–102
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Lipid-core micelles for targeted drug delivery. Curr Drug Deliv 2005;2:319–27
   PubMedGoogle Scholar
• Chernenko T, Sawant RR, Miljkovic M, et al. Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition. Mol Pharm 2012;9:930–6
   PubMed Web of Science ®Google Scholar
• Wang J, Mongayt D, Torchilin VP. Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. J Drug Target 2005;13:73–80
   PubMed Web of Science ®Google Scholar
• Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997;40:S3–8
   PubMed Web of Science ®Google Scholar
• Deng WJ, Yang XQ, Liang YJ, et al. FG020326-loaded nanoparticle with PEG and PDLLA improved pharmacodynamics of reversing multidrug resistance in vitro and in vivo. Acta Pharmacol Sin 2007;28:913–20
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu L, Han L, et al. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int J Pharm 2007;337:63–73
   PubMed Web of Science ®Google Scholar
• Alvarez-Lorenzo C, Sosnik A, Concheiro A. PEO-PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr Drug Targets 2011;12:1112–30
   PubMed Web of Science ®Google Scholar
• Dong X, Mumper RJ. Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (Lond) 2010;5:597–615
   PubMed Web of Science ®Google Scholar
• Wang J, Qu H, Jin L, et al. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. J Pharm Sci 2011;100:2267–77
   PubMed Web of Science ®Google Scholar
• Li L, Tan YB. Preparation and properties of mixed micelles made of pluronic polymer and PEG-PE. J Colloid Interface Sci 2008;317:326–31
   PubMed Web of Science ®Google Scholar
• Zhang YF, Wang JC, Bian DY, et al. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies. Eur J Pharm Biopharm 2010;74:467–73
   PubMed Web of Science ®Google Scholar
• Roy A, Singh MS, Upadhyay P, Bhaskar S. Combined chemo-immunotherapy as a prospective strategy to combat cancer: a nanoparticle based approach. Mol Pharm 2010;7:1778–88
   PubMed Web of Science ®Google Scholar
• Katragadda U, Teng Q, Rayaprolu BM, et al. Multi-drug delivery to tumor cells via micellar nanocarriers. Int J Pharm 2011;419:281–6
   PubMed Web of Science ®Google Scholar
• Salmaso S, Bersani S, Pirazzini M, Caliceti P. pH-sensitive PEG-based micelles for tumor targeting. J Drug Target 2011;19:303–13
   PubMed Web of Science ®Google Scholar
• Beilvert A, Cormode DP, Chaubet F, et al. Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque. Magn Reson Med 2009;62:1195–201
   PubMed Web of Science ®Google Scholar
• Judge A, Mcclintock K, Phelps JR, Maclachlan I. Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. Mol Ther 2006;13:328–37
   PubMed Web of Science ®Google Scholar
• Dams ET, Laverman P, Oyen WJ, et al. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. J Pharmacol Exp Ther 2000;292:1071–9
   PubMed Web of Science ®Google Scholar